Carboplatin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Carboplatin Injection (injection) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Apr 28, 2023. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Teva Pharmaceuticals USA, Inc.
- Package NDC
- 0703-4244-01
- Dosage Form
- Injection
- Presentation
- Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01)
- Initial Posting
- Apr 28, 2023
Reason
Other